Business Standard

Vaccine policy group seeks more lab data on tests for mixing Covid doses

NTAGI has a month to go before it gives its advice to the government on inoculation strategy.

vaccine
Premium

Sohini Das Mumbai
The organisation that makes India’s vaccination strategy has sought more laboratory data before it decides on advising mixing Covid-19 doses—a medical practice called heterologous boosting.

The National Technical Advisory Group on Immunisation (NTAGI) has month to go before its gives its advice to the government. It has sought more laboratory data from the Christian Medical College (CMC), Vellore, where researchers are conducting a study on mixing Covid-19 vaccines, said sources in the know.

CMC will conduct more tests on neutralising antibodies on 400 subjects enrolled for a study on testing how mixing Covaxin (a vaccine manufactured by Bharat Biotech) and Covishield (manufactured

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 31 2022 | 2:09 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com